Skip to Content

Notice

Blood Products Advisory Committee; Amendment of Notice

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is announcing an amendment to the notice of meeting of the Blood Products Advisory Committee. This meeting was announced in the Federal Register of February 25, 2004 (69 FR 8666). The amendment is being made to reflect a change in the Location portion of the document. The street address of the hotel was originally posted as 2 Montgomery Ave. The correct street address is 2 Montgomery Village Ave. There are no other changes.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Linda A. Smallwood, Center for Biologics Evaluation and Research (HFM-302), Food and Drug Administration, 1401 Rockville Pike, Rockville, MD 20852, 301-827-3514.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

In the Federal Register of February 25, 2004, FDA announced that a meeting of the Blood Products Advisory Committee would be held on March 18 and 19, 2004. On page 8666, in the first column, the Location portion of the document is amended to read as follows:

Location: Holiday Inn, Gaithersburg, 2 Montgomery Village Ave., Gaithersburg, MD 20877.

This notice is issued under the Federal Advisory Committee Act (5 U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees.

Start Signature

Dated: March 3, 2004.

Peter J. Pitts,

Associate Commissioner for External Relations.

End Signature End Supplemental Information

[FR Doc. 04-5239 Filed 3-8-04; 8:45 am]

BILLING CODE 4160-01-S